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For future application of induced pluripotent stem
cell (iPSC) technology, the ability to assess the
overall quality of iPSC clones will be an important
issue. Here we show that the histone variant H2A.X
is a functional marker that can distinguish the devel-
opmental potentials of mouse iPSC lines. We found
that H2A.X is specifically targeted to and negatively
regulates extraembryonic lineage gene expression
in embryonic stem cells (ESCs) and prevents tro-
phectoderm lineage differentiation. ESC-specific
H2A.X deposition patterns are faithfully recapitulated
in iPSCs that support the development of ‘‘all-iPS’’
animals via tetraploid complementation, the most
stringent test available of iPSC quality. In contrast,
iPSCs that fail to support all-iPS embryonic develop-
ment show aberrant H2A.X deposition, upregulation
of extraembryonic lineage genes, and a predisposi-
tion to extraembryonic differentiation. Thus, our
work has highlighted an epigenetic mechanism for
maintaining cell lineage commitment in ESCs and
iPSCs that can be used to distinguish the quality of
iPSC lines.
INTRODUCTION
Primary cell lines derived from various early embryonic tissues
serve as valuable model systems to study embryonic develop-
ment, such as embryonic stem cells (ESCs) derived from the in-
ner cell mass and trophoblast stem cells (TSCs) derived from the
trophectoderm. Previous studies have shown that cell lineage
commitment in ESCs can be overridden by depleting Oct4
(Niwa et al., 2000), or overexpressing Cdx2, a critical transcrip-
tion factor for inducing extraembryonic lineage development at
early embryogenesis (Niwa et al., 2005; Strumpf et al., 2005).
On the other hand, commitment to epiblast lineages needs to
be meticulously maintained during ESC self-renewal to preserveCell Spluripotency. The molecular mechanisms that underlie these
regulatory pathways are not well understood.
The advent of induced pluripotent stem cells (iPSCs) has pre-
sented a promising approach for regenerative medicine. The
molecular signature of faithful pluripotency is not yet well under-
stood for iPSCs, although variability in the developmental poten-
tials of iPSC lines has been well documented (Buganim et al.,
2013; Cahan and Daley, 2013; Narsinh et al., 2011). For example,
iPSC clones are surprisingly variable in terms of supporting the
development of the ‘‘all-iPS’’ animals as shown by tetraploid
(4N) complementation assays (Liu et al., 2010; Stadtfeld et al.,
2010a). Only a small number of pluripotent iPS clones (referred
to as 4N+ iPSCs) can fully support embryonic development
in vivo, whereas a large number of the iPSC clones (referred to
as 4N iPSCs) cannot (Liu et al., 2010; Stadtfeld et al., 2010a).
Intriguingly, the 4N iPSC clones express the same levels of
pluripotent markers as the 4N+ iPSC clones, indicating that yet
unidentified mechanisms must be misregulated (Liu et al.,
2010; Stadtfeld et al., 2010a). It is conceivable that iPSC clones
also need to maintain the same commitment to epiblast lineages
as ESCs to achieve high-quality status.
Accumulating evidence has demonstrated the critical roles of
epigenetic mechanisms in cell fate transition (Orkin and Hoched-
linger, 2011). Chromatin remodeling and histone modifications
have been implicated in regulating ESC differentiation or cellular
reprogramming (Orkin and Hochedlinger, 2011). However, the
role of another important aspect of chromatin biology, the incor-
poration of histone variants, is relatively unknown (Banaszynski
et al., 2010). Histone variant proteins, which carry notable differ-
ences in primary amino acid sequences, are often expressed
at low levels in comparison to themajor histone isoforms (Banas-
zynski et al., 2010). For example, H2A.X, a minor variant of
histone H2A, constitutes only 1%–10% of the nucleosomes
in the mammalian genome. H2A.X is phosphorylated by the
ATM/ATR kinases (often referred to as g-H2A.X phosphorylation)
during the DNA damage response (Redon et al., 2002). Intrigu-
ingly, recent studies have implicated H2A.X in cellular reprog-
ramming and shown that g-H2A.X phosphorylation level is
elevated during reprogramming (Gonza´lez et al., 2013; Mario´n
et al., 2009; Mu¨ller et al., 2012). Despite these observations,
the functions of H2A.X in ESCs and iPSCs remain elusive.tem Cell 15, 281–294, September 4, 2014 ª2014 Elsevier Inc. 281
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Figure 1. H2A.X Plays a Role in Targeting Extraembryonic Genes
(A) Schematics of H2A.X ChIP-seq and bioinformatic analyses. First, ESC and MEF H2A.X peaks were determined against H2A.X KO ESC or MEF controls,
IgG control, and DNA input. Then, an established hidden Markov model (RSEG) was used to obtain ESC-specific H2A.X deposition regions.
(B) The specificity of H2A.X ChIPmethod. DNA sample libraries copurified with H2A.X antibodies or isolated from input were amplified by 1,000-fold. Note that no
signals were detected in the H2A.X KO DNA sample library.
(C) A locus on Chr18 (30–32 Mb) that is specifically enriched for H2A.X deposition in ESCs. Y axis: normalized H2A.X ChIP-seq signals (reads per million) in ESCs
(orange) and MEFs (gray).
(D) The normalizedH2A.X ChIP-seq signals (reads permillion) in ESC-specific H2A.X deposition regions (orange) and Cdx2-bound enhancers (purple) at the Dab2
and Gata3 loci.
(legend continued on next page)
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H2A.X Serves as an Epigenetic Mark for iPSCsHere, we report that H2A.X plays critical roles in repressing
extraembryonic gene expression in pluripotent stem cells, and
that its unique deposition pattern serves as a functional epige-
netic marker to evaluate the quality of iPSCs.
RESULTS
H2A.X Is Specifically Deposited at Extraembryonic
Lineage Genes in ESCs
To investigate the functions of H2A.X in pluripotent stem cells,
we examined H2A.X deposition patterns in ESCs and primary
MEFs (mouse embryonic fibroblasts) with chromatin immuno-
precipitation sequencing (ChIP-seq) approaches (Figure 1A).
We identified 19,637 peaks in wild-type ESCs and 6,509 peaks
in wild-type MEFs with specific antibodies raised against
H2A.X, using whole cell extraction input DNA, H2A.X knockout
ChIP sample, or IgG ChIP sample as negative controls (see Sup-
plemental Experimental Procedures available online). The
amount of DNA molecules copurified from H2A.X knockout
(KO) samples was below the detection limit after more than
1,000-fold amplification of the sequencing library and therefore,
no sequencing peaks were generated from H2A.X KO samples
(Figure 1B). We further confirmed H2A.X peaks in ESCs
and MEFs with ChIP-qPCR approaches (Figure S1, ESC: 14
randomly chosen peaks, false discovery rate [FDR] < 0.1;
MEFs: five randomly chosen peaks, FDR < 0.2). To completely
rule out the potential nonspecificity of H2A.X antibodies, we re-
constituted H2A.X KO cells with a Flag-tagged H2A.X construct
and performed ChIP-seq with anti-Flag antibodies. The results
from this approach were strongly correlated with the endoge-
nous H2A.X peaks identified in wild-type cells (80% overlap,
p < 1.03 106; Figure S1). Thus, we concluded that our strategy
accurately identified the genome-wide deposition patterns of
H2A.X.
To identify the differential H2A.X deposition patterns between
ESCs and MEFs, we used a well-established hidden Markov
model algorithm (RSEG; Fragola et al., 2013; Micsinai et al.,
2012; Song and Smith, 2011) that can reliably identify histone
modification alterations after differentiation (Brinkman et al.,
2012). We identified 9,233 genomic regions where H2A.X depo-
sition in ESCs is significantly more enriched than in MEFs (Fig-
ure 1C; referred to as ESC-specific H2A.X deposition regions
hereafter).
Our in-depth bioinformatics analyses revealed a surprising
enrichment of Cdx2 binding sites in ESC-specific H2A.X deposi-
tion regions. Strikingly, 63.5% of the ESC-specific H2A.X
deposition regions are overlapped with Cdx2-targeted sites
(Nishiyama et al., 2009), such as the Gata3 and Dab2 loci (p <
1.0 3 106 versus genome random; Figures 1D and 1E).
On the other hand, such a strong correlation was not observed(E) At the genome-wide level, 63.5% of ESC-specific H2A.X deposition regions a
random), whereas MEF-H2A.X peaks covered only 1.5% of Cdx2 targets (see Fi
(F) One of the DNA binding motifs of H2A.X (see Figure S1) is similar to the majo
(G) Comparative H2A.X deposition in TSCs on whole Chr12. Y axis: relative H
determined with RSEG. Positive value: regions enriched for H2A.X deposition ov
(green bars).
(H) At the genome-wide level, 38% of the regions devoid of H2A.X deposition in
random).
Cell Sin MEFs (Figure S1). Cdx2 is not usually expressed in ESCs.
Overexpression of Cdx2 is sufficient to induce extraembryonic
lineage differentiation by upregulating critical extraembryonic
lineage genes (Nishiyama et al., 2009; Niwa et al., 2005). When
overexpressed, Cdx2 binds to enhancer sites of the critical
extraembryonic genes and activates their expression (Nishiyama
et al., 2009). In agreement with the above findings, bioinformatic
analyses (with ‘‘HOMER’’; Heinz et al., 2010 and ‘‘STAMP’’;
Mahony and Benos, 2007) identified several DNA motifs in
ESC-specific H2A.X deposition regions that are similar to Cdx2
DNA binding motifs (Figure 1F and Figure S1). Of note, the
core pluripotency genes or genes involved in the germ layer
development did not show strong correlations with ESC-specific
H2A.X deposition regions (data not shown).
In addition to pluripotent stem cells that generally contribute
to embryonic tissues, trophoblast stem cells (TSCs), which
give rise to extraembryonic tissues, have been widely used
especially for studying extraembryonic differentiation (Oda
et al., 2006; Rossant, 2007). Because H2A.X deposition was
strongly correlated to the silenced, extraembryonic genes in
ESCs, we investigated whether this correlation would change
in TSCs in which these genes are highly expressed. Interestingly,
we identified 15,611 regions devoid of H2A.X deposition in TSCs
in comparison to ESCs (Figure 1G), 38% of which were located
at the Cdx2 binding sites (Figure 1H; p < 1.0 3 105 versus
genome random). Based on these findings, we hypothesized
that H2A.X may play a specific, yet unknown role in regulating
the expression of extraembryonic genes in ESCs.
H2A.X Plays a Critical Role in the Transcriptional
Repression of Extraembryonic Lineage Genes in ESCs
To test this hypothesis, we used RNA sequencing (RNA-seq)
approaches to interrogate the transcriptomes of H2A.X KO
ESCs and control ESCs (Figure 2A and Figure S2). To avoid
potential long-term culture effects, we generated H2A.X KO
ESCs from H2A.Xfloxed/floxed ESCs (Bassing et al., 2002) via
Cre-mediated deletion and used them immediately (passage
five to seven) for the ensuing analyses. The efficiency of the
H2A.X allele deletion was demonstrated by PCR approaches
(Figure S2A). Bioinformatic analyses demonstrated that H2A.X
deficiency leads to upregulation of 636 genes and downregula-
tion of only a few. Gene ontology analysis demonstrated that
genes involved in development are significantly enriched in
H2A.X-regulated genes (Figure 2B). Most interestingly, H2A.X-
regulated genes are significantly overlapped with genes regu-
lated by three key extraembryonic lineage differentiation factors,
Cdx2, Eomes, and Gata3 (Figure 2C; p = 5.13 1046; hypergeo-
metric test). To confirm these results, we used a qRT-PCR
approach to examine the mRNA levels (Figure 2D). This
approach confirmed the specific upregulation of extraembryonicre overlapped with 44% of Cdx2 binding sites (p < 1.0 3 106 versus genome
gure S1).
r Cdx2 motif (analyzed by ‘‘STAMP,’’ E-value = 1.66 3 1016).
2A.X deposition levels (TSCs versus ESCs) are shown in enrichment scores
er ESCs (gray); negative values: regions devoid of H2A.X deposition over ESC
TSCs are overlapped with Cdx2 binding sites (p < 1.0 3 105 versus genome
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Figure 2. H2A.X Plays a Critical Role in Repressing Extraembryonic Gene Expression
(A) The p value distribution of all genes in RNA-seq analysis of H2A.X KO ESCs (versus control ESCs). y axis: number of genes associated with a specified p value;
x axis: significance scores derived from p value (log10 [p value]). Several TE lineage markers are labeled in red.
(B) Gene ontology term analysis of H2A.X-repressed genes. Shown are the top ten biological processes.
(C) Upregulated genes identified in RNA-seq (H2A.X/ ESCs versus control ESCs) are significantly overlapped (48.3%) with TE lineage genes (regulated by
Cdx2, Gata3, or Eomes; p = 5.17 3 1046, hypergeometric test).
(legend continued on next page)
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H2A.X Serves as an Epigenetic Mark for iPSCslineage genes in H2A.X KO ESCs, such as Cdx2, Gata3, and
Hand1 (Figures 2A and 2D; Adachi et al., 2013; Niwa et al.,
2005; Ralston et al., 2010). On the other hand, the pluripotency
genes or germ layer (three lineages) development genes were
unaffected (Figures 2A and 2D). We also generated H2A.X-defi-
cient ESC lines with small hairpin RNA (shRNA) knockdown and
analyzed the early passage cells (passages two to four). TE line-
age genes were also specifically upregulated in H2A.X knock-
down ESCs (Figures S2C).
Because H2A.X is well known for its role in the DNA damage
response (Redon et al., 2002), we further investigated and ruled
out the trivial explanation that the newly observed function in
transcriptional repression was related to genomic instability.
First, we reconstituted H2A.X-deficient ESC with wild-type
(WT) H2A.X constructs. This approach was able to successfully
repress extraembryonic genes that had been aberrantly upregu-
lated in H2A.X-deficient ESCs (Figure S2D). Second, we used
an array-CGH approach to detect genome-wide copy number
variations (CNVs) in H2A.X KO ESCs. We identified 30 significant
CNV regions in H2A.X KO (more than 35 passages) ESCs (cutoff
> ±0.3; Supplemental Experimental Procedures). Most of the
CNVs were found in ‘‘gene deserts;’’ and none was located in
the vicinity of the genomic loci encoding H2A.X-regulated genes
(at least within 100 kb upstream or downstream; Figures S2E and
S2F). These results demonstrated that the detected function of
H2A.X is not due to potential secondary mutations.
Because H2A.X had been rarely implicated in regulating gene
expression, we investigated the mechanisms underlying H2A.X-
mediated repression. Previous studies showed that overex-
pression of Cdx2 efficiently upregulates TE lineage genes and
triggers extraembryonic lineage differentiation (Nishiyama
et al., 2009). The above results indicated that H2A.X may regu-
late Cdx2 binding during extraembryonic lineage differentiation.
To test this hypothesis, we utilized an inducible ESC line that
overexpresses Cdx2 with a defined expression level and kinetics
(Nishiyama et al., 2009). We depleted H2A.X in these cells with
an RNAi approach and then induced Cdx2 expression. At day
5 postinduction, Cdx2 expression was already substantial,
whereas the extraembryonic genes had not been significantly
upregulated yet. Thus, most of the ESCs had not changed the
cell fate and the pluripotency markers were still highly expressed
at this time (Nishiyama et al., 2009). We used a ChIP approach to
compare the occupancy of Cdx2 at the enhancers in control and
H2A.X-deficient ESCs at this stage. As expected, Cdx2 bound to
the putative enhancer sites at the extraembryonic genes more
efficiently in H2A.X-deficient ESCs than WT controls (Figure 2E).
Despite of the prominent role of Cdx2 in extraembryonic line-
age differentiation, the regulatory mechanisms for its binding
to enhancers remained elusive (Nishiyama et al., 2009). Thus,
we next investigated how H2A.X regulates Cdx2 binding at the(D) Consistent with the RNA-seq results, the qRT-PCR approach confirmed tha
bryonic, extraembryonic lineage genes; pluripotency, ESC pluripotency genes; g
GAPDH and H2A.X. The average of triplicate experiments (*p < 0.05, t test) is sh
(E) ChIP-qPCR approach demonstrated that H2A.X deficiency significantly incre
and induction of Cdx2 expression. Bottom: Cdx2 binding (relative ChIP signals
periments (p < 0.05, t test) is shown. Error bars represent SEM.
(F) ChIP-qPCR approach demonstrated that H2A.X deficiency significantly redu
extraembryonic gene loci. The average of triplicate experiments (*p < 0.05, t tes
Cell Senhancer sites. We reasoned that H2A.X deposition at these en-
hancers may regulate local chromatin structures. Previous re-
sults showed that the H3K9 methylation (Bilodeau et al., 2009;
Matsui et al., 2010; Yuan et al., 2009) machineries repress extra-
embryonic lineage genes in ESCs. Indeed, we demonstrated that
H2A.X deposition was critical for maintaining H3K9Me3 levels at
extraembryonic gene enhancers (Figure 2F). This effect seemed
to be specific because H3K27Me3 levels remained unchanged
(Figure S2G), which is consistent with the lack of H3K27me3-
mediated repression in the regulation of extraembryonic gene
expression (Bracken et al., 2006; Mager et al., 2003). Because
H3K9 methylation facilitates heterochromatin formation, it is
conceivable that H2A.X deposition interferes with Cdx2 binding
by maintaining compact chromatin structures at the enhancers.
These results demonstrated that H2A.X directly represses
extraembryonic genes in ESCs via regulating heterochromatin
structures at the Cdx2-targeted putative enhancer sites. Taken
together, these results demonstrated that H2A.X plays a direct
role in repressing extraembryonic genes in ESCs.
H2A.X Deposition Serves as an Epigenetic Mark for
Distinguishing Pluripotent iPSC Clones
Given the marked differences of H2A.X deposition patterns be-
tween ESCs and MEFs, we asked if ESC-specific H2A.X deposi-
tion and function can be faithfully recapitulated in iPSCs. Thus,
we next investigated H2A.X depositions in a cohort of iPSC lines
generated by the secondary iPS system (n = 9; Stadtfeld et al.,
2010a, 2010b), so that the variations in genetic backgrounds,
reprogramming efficiency, and kinetics are minimal (Stadtfeld
et al., 2010a, 2010b). Intriguingly, despite similar expression
levels of endogenous pluripotent markers, the differences
among developmental potentials of these iPSC clones were
revealed by tetraploid complementation assays (Stadtfeld
et al., 2010a, 2010b). Some iPSC lines (n = 3) were capable of
generating viable ‘‘all-iPS’’ animals (referred to as ‘‘4N+ iPSC’’
hereafter), whereas the others (n = 6) were not (referred to
as ‘‘4N iPSC’’ hereafter; see Table S1 for a summary of the
phenotypes).
First, we took into the consideration that H2A.X deposition
may vary among ESC lines because they were adapted from
different inbred strains. Thus, it is critical to determine the
threshold for our analysis, i.e., natural variations of H2A.X
deposition among different ESC lines that are not associated
with developmental phenotypes. We determined the H2A.X
depositions in three ESC lines (two on the 129 svj/C57BL/6
mixed background, which is identical to the iPSC lines
used in this study and one on a pure C57BL/6 background).
Because these strains were capable of generating germline-
transmitting chimeras and supporting whole animal develop-
ment using 4N complementation assay, the small differencest only extraembryonic genes were upregulated in H2A.X KO ESCs. Extra-em-
erm layer, three germ layer (ecto-, meso-, and endoderm) lineage genes; Ctrl,
own. Error bars represent SEM.
ased Cdx2 binding to the targeted sites. Top: schematic of H2A.X knockdown
versus input) at eight Cdx2-targeted enhancers. The average of triplicate ex-
ced the levels of H3K9Me3, but not H3K27Me3 levels (see Figure S2) at the
t) is shown. Error bars represent SEM.
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Figure 3. H2A.X Depositions Are Strongly Correlated with the Developmental Potentials of the iPSC Lines
(A) Unsupervised hierarchical cluster analysis usingH2A.XChIP-seq signals (shown in heatmap) successfully distinguished the 4N iPSCs (n = 6) from 4N+ iPSCs
(n = 3) and ESCs (n = 3); only 4N+ iPSC lines (n = 3) were grouped into the same clade as ESCs (n = 3). Rows: ESC and iPSC lines as labeled. Columns: genomic
regions with ESC-specific H2A.X deposition. Blue, decreased; green, similar or no change.
(B) A box plot illustrated that the 4N iPSC lines (n = 3) had significantly more genomic regions devoid of H2A.X deposition than those in 4N+ iPSC lines (n = 3) or
ESC lines (n = 3; p < 0.001, t test). 4N+ iPSC lines were similar to ESC lines (no p value).
(C) Comparative H2A.X depositions in 4N+ iPSCs and 4N iPSCs on whole Chr14. Shown are the H2A.X ChIP signals in iPSCs relative to ESCs. Y axis:
enrichment scores determined with RSEG. Positive value: regions enriched for H2A.X deposition over control ESCs (gray); negative values: regions devoid of
H2A.X deposition over control ESCs (blue bars).
(D) Immunblotting demonstrated that the total H2A.X protein levels in ESCs, 4N+ iPSCs, and 4N iPSCs (n = 2 for each group) were similar.
(E) Venn diagram showed that genome regions devoid of H2A.X deposition in all 4N iPSC lines are significantly overlapped with the Cdx2-targeted enhancer
sites (48%, p < 1.0 3 106 versus genome random).
(legend continued on next page)
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H2A.X Serves as an Epigenetic Mark for iPSCsin H2A.X deposition (less than 7% of the ESC-specific H2A.X
deposition regions) among these lines seems most likely incon-
sequential. Thus, we used the variations among these lines
as the threshold for the following analyses to distinguish the
quality of iPSC lines.
Second, we performed H2A.X ChIP-seq experiments for the
iPSC lines and compared their deposition patterns with those
of the ESC control (RSEG; Song and Smith, 2011; and Experi-
mental Procedures). Our analysis clearly segregated the 4N+
and 4N iPSC lines into two distinct groups with an unsuper-
vised hierarchical cluster analysis (Figure 3A). All 4N+ iPSC lines
(n = 3) whose H2A.X depositions were indistinguishable from the
control ESC were clustered with ESCs (n = 3), whereas the 4N
iPSC lines (n = 6) whose H2A.X depositions were quite distinct
from ESCs were clustered into a separate clade (Figure 3A). At
a genome-wide level, the most prominent feature of the 4N
iPSC lines (n = 6) was a large number of genomic regions devoid
of H2A.X deposition (more than 22% of the ESC-specific H2A.X
deposition regions; Figure 3B; p < 0.001). For example, H2A.X
deposition was diminished at a large number of genomic regions
onChr14 in 4N- iPSC lines, whereas it was similar between ESCs
and 4N+ iPSCs (Figure 3C). Of note, there are no differences
in the overall protein levels of H2A.X among ESCs and the 4N+
and 4N iPSCs (Figure 3D).
Bioinformatic analyses further revealed that the genomic
regions devoid of H2A.X deposition in 4N iPSCs were signifi-
cantly overlapped with Cdx2 bound enhancer sites (Figure 3E;
48%, p < 1.0 3 106 versus genome random). For example,
H2A.X deposition were significantly diminished at critical extra-
embryonic gene loci in all 4N iPSC lines, such as Fgfr2
(Haffner-Krausz et al., 1999; Figure 3F), Gata2, and Gata3 (Ral-
ston et al., 2010; Figure S3). Thus, these results demonstrated
that H2A.X deposition can serve as an epigenetic mark for distin-
guishing the in vivo developmental potentials of iPSC lines.
Extraembryonic Genes Are Upregulated in 4N– iPSC
Lines, Reminiscent of H2A.X-Deficient ESCs
The above results indicated that the 4N iPSC lines may also
upregulate H2A.X-dependent genes, which prompted us to
investigate the functions of H2A.X in 4N+ and 4N iPSC lines.
However, previous studies using gene expression microarray
showed that only a limited number of genes changed their
expression in 4N iPSCs (Stadtfeld et al., 2010a). We noticed
that most H2A.X-regulated genes were expressed at relatively
low levels in ESCs (Figure S2B), so gene expression microarray
may not quantify their expression levels reliably. Thus, we used
a RNA-seq approach, which is more sensitive than microarray,
to interrogate the transcriptomes in the 4N (n = 2) and 4N+
(n = 2) iPSCs (Figure 4A). In each 4N iPSC clone, 100 genes
were affected in comparison to 4N+ iPSCs (Figure 4A). Only a
few genes are downregulated in the 4N iPSC lines, which are
mainly composed of the transcripts from the DLK1-Dio3 locus,
consistent with previous reports (Stadtfeld et al., 2010a; see
Discussion).(F) The relative H2A.X deposition levels (versus ESC control) are shown in five 4N
Fgfr2. Y axis: relative H2A.X deposition levels (iPSC versus ESC) are shown in en
lines because H2A.X depositions are identical to those of the ESC control.
See also Figure S3 and Table S1.
Cell SRemarkably, nearly 70%of the upregulated genes in 4N iPSC
are encoded from the genomic regions devoid of H2A.X deposi-
tions in 4N iPSC, indicative of a direct role of H2A.X in regulating
their transcription (Figure 4B). Thesegenes are significantly corre-
lated with the upregulated genes in H2A.X-deficient ESCs (Fig-
ure 4C), as well as the genes upregulated by Cdx2, Eomes, and
Gata3 during extraembryonic lineage differentiation (Figure 4D).
On the other hand, pluripotency genes or genes involved in
germ layer development were unaffected. We used a qRT-PCR
approach to examine the mRNA levels in 4N iPSCs and con-
firmed the upregulation of TE lineage genes (Figure 4E). Further-
more, the H3K9Me3 (Figure 4F), but not the H3K27Me3 levels
(Figure S4) in 4N iPSCs are significantly decreased at the
Cdx2 targeted sites of extraembryonic genes, which is also remi-
niscent of the H2A.X KO ESCs (Figure 2F). Thus, we concluded
that H2A.X deposition defects in 4N iPSCs results in upregu-
lation of extraembryonic genes, reminiscent of H2A.X KO ESCs.
H2A.X Dysfunction Primes ESCs and iPSCs to
Extraembryonic Lineage Differentiation
Although tetraploid complementation is a rigorous develop-
mental assay, it is also tedious and technically challenging.
Encouraged by the above findings, we sought to develop func-
tional assays based on them to distinguish the developmental
potentials of the iPSC clones. Because 4N iPSCs aberrantly
upregulated the extraembryonic genes, we investigated if they
were primed to extraembryonic lineage differentiation.
First, we used a well-established protocol that induces extra-
embryonic lineage differentiation by reducing Oct4 levels (Niwa
et al., 2000, 2005). To this end, we used an ESC line in which
theOct4 expression is controlled by a tetracycline-inducible sys-
tem (Ivanova et al., 2006). We depleted H2A.X in these cells via
RNAi and turned off Oct4 expression by removing doxycycline
to induce extraembryonic lineage differentiation. With this
approach, critical extraembryonic lineage genes (Cdx2, Eomes,
and Elf5) were upregulated in both H2A.X and control knock-
down cells (Figure 5A). However, the induction levels of these
geneswere significantly higher in H2A.X knockdown than control
knockdown ESCs (Figure 5A). We next used an RNAi approach
to deplete Oct4 in 4N or 4N+ iPSC and demonstrated that crit-
ical extraembryonic lineage genes (Cdx2, Gata3, and Plac1)
were induced at much higher levels in 4N iPSC than in 4N+
iPSC (Figure 5B). In addition, we depleted H2A.X in the ESC
line in which TE lineage differentiation can be induced by Cdx2
expression (Nishiyama et al., 2009 and Figure S5A). In compari-
son with WT ESC, trophoblast marker expressions were much
higher in H2A.X knockdown ESCs after Cdx2 overexpression
(Figure S5A). We also differentiated the trophoblast-like cells
induced by Cdx2 overexpression to giant-cell-like cells with a
standard protocol (Ng et al., 2008). Consistently, significantly
more giant-like cells were generated on the H2A.X-deficient
background than the WT control (Figure S5B).
Second, because previous studies showed that TSC culture
medium, which mainly contains Fgf4 and heparin (referred to iPSC lines and two 4N+ iPSC lines at a critical extraembryonic gene locus,
richment scores determined with RSEG. No signals are displayed in 4N+ iPSC
tem Cell 15, 281–294, September 4, 2014 ª2014 Elsevier Inc. 287
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Figure 4. H2A.X Deposition Defects in 4N– iPSCs Result in Aberrant Upregulation of Extraembryonic Genes
(A) Comparative RNA-seq results: 4N iPSCs versus 4N+ iPSCs. Y axis: the relative enrichment in 4NiPSCs (versus 4N+ iPSCs, log2); x axis: normalized
expression level of individual genes. Red dots: FDR < 0.01.
(B) In 4N iPSCs, 68% of the upregulated genes are located in the genomic regions devoid of H2A.X deposition (p < 0.001 versus genome random).
(C) The upregulated genes in 4N iPSCs are significantly overlapped with those in H2A.X KO ESCs (p = 2.75 3 1022, hypergeometric test).
(D) The upregulated genes in 4N iPSCs are significantly overlapped (45%) with TE lineage genes (regulated by Cdx2, Gata3, or Eomes; p = 1.61 3 107, hy-
pergeometric test).
(E) The qRT-PCR approach confirmed that only extraembryonic genes were upregulated in 4N iPSCs. Extra-embryonic, extraembryonic lineage genes; plu-
ripotency, ESC pluripotency genes; Germ layer, three germ layer (ectoderm, mesoderm, and endoderm) lineages genes; Ctrl, GAPDH and H2A.X. Error bars
represent SEM.
(F)A ChIP-qPCR approach demonstrated that H2A.X deficiency significantly reduced the levels of H3K9Me3 at the extraembryonic gene loci. H3K27Me3 levels
were unchanged (see Figure S4). Error bars represent SEM.
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H2A.X Serves as an Epigenetic Mark for iPSCsas TS condition), can trigger extraembryonic lineage gene
expression in Tet1-deficient ESC (Koh et al., 2011), we cultured
a cohort ofWT ESC, H2A.X KO ESC, 4N iPSCs, and 4N+ iPSCs
under TSC condition for 96 hr. The critical extraembryonic line-
age genes, such asCdx2,Hand1,Gata3, and Elf5were all signif-
icantly higher in H2A.X KO ESCs or 4N iPSCs, whereas the
changes were very modest in the control ESCs or 4N+ iPSCs
(Figures 5C and 5D).
Third, we investigated whether the trophoblast-like cells
induced from H2A.X KO ESCs and 4N iPSCs under TS condi-288 Cell Stem Cell 15, 281–294, September 4, 2014 ª2014 Elsevier Itions could contribute to the extraembryonic lineage in devel-
oping embryos (Figure 6). We engrafted a cohort of cell lines,
i.e., WT ESCs, H2A.X KO ESCs, 4N+ iPSCs (n = 2), and 4N
iPSCs (n = 3) to four-cell stage mouse embryos and cultured
them ex vivo until they reached the blastocyst stage. As ex-
pected, all cell lines contributed to the inner cell mass. However,
the H2A.X KO ESCs and 4N iPSCs (n = 3) derived cells contrib-
uted to the trophectoderm layer at a much higher frequency than
the control ESCs and 4N+ iPSCs (n = 2; Figures 6A and 6B). In
agreement with these results, the engrafted H2A.X KO ESCs ornc.
A B
C D
Figure 5. In Vitro TE Lineage Differentiation
Assays Distinguish the Developmental
Potentials of iPSC Clones
(A) An ESC line in which Oct4 expression was
controlled by the ‘‘Tet-On’’ system (Ivanova et al.,
2006) was used in TE lineage differentiation. H2A.X
was first depleted by an RNAi approach. Then, the
H2A.X knockdown or control knockdown cells
were cultured without Oct4 expression for 5 days
(by removing doxycycline). Cdx2, Eomes, and
Elf5 expressions were examined with qRT-PCR.
Y axis: relative gene expression level (Oct4
versus Oct4+ control). The TE markers were
further increased in H2A.X knockdown cells after
shutting down Oct4 expression (*p < 0.05; **p <
0.01, t test). Error bars represent SEM.
(B) Oct4 was depleted by RNAi approach in 4N+ or
4N iPSC lines. qRT-PCR approaches demon-
strated that the extraembryonic lineage markers in
4N iPSCs were significantly higher than those
in the 4N+ iPSC. y axis: the relative enrichment
(Oct4 knockdown versus Control knockdown).
Error bars represent SEM.
(C) H2A.X/ and control ESCs were cultured un-
der ES or TS culture condition for 96 hr without
feeder cells. qRT-PCR approaches demonstrated
that the extraembryonic lineage marker expres-
sions in H2A.X/ ESCs were significantly higher
than those in control ESCs. Y axis: the relative
expression level (log2, TS media culture versus ES
media culture control). Error bars represent SEM.
(D) Similar experiments were performed in 4N
iPSCs and 4N+ iPSCs under ES or TS culture
condition. Error bars represent SEM. See also
Figure S5.
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H2A.X Serves as an Epigenetic Mark for iPSCs4N iPSCs also expressed a TE lineage marker, Cdx2 (Figures
6C and 6D). Collectively, the differentiation and the chimera as-
says provide additional supports for H2A.X’s role in repressing
extraembryonic gene expression in ESCs and iPSCs.
These results demonstrated an unexpected role of H2A.X in
iPSCs, which raised an interesting question about H2A.X func-
tions during reprogramming. Because a recent study has re-
ported that DNA repair factors are also required for efficient
reprogramming (Gonza´lez et al., 2013), we used the secondary
iPS system (Stadtfeld et al., 2010b) to investigate reprogram-
ming efficiency in H2A.X-deficient backgrounds. Because
H2A.X KO MEFs cells are prone to genome instability (Celeste
et al., 2002), we used an RNAi approach to deplete H2A.X and
induced reprogramming immediately. Whereas Oct4-positive
colonies were obtained with expected frequency (0.1%) from
the control MEF cells 30 days postinduction, no such colonies
were obtained from the H2A.X-depleted MEFs (Figure S6). We
further demonstrated that the number of alkaline phosphatase-
positive colonies (at days 10–14) were also greatly reduced
when H2A.X was depleted, indicating that H2A.X may be
required at the early stage of reprogramming (Figure S6). Thus,
these data demonstrated that H2A.X plays a critical role during
cellular reprogramming.Cell SDISCUSSION
In summary, we demonstrated that H2A.X deposition serves as a
functional epigenetic mark for distinguishing the developmental
potentials of iPSC lines. Several recent studies have reported
the intriguing variations among the developmental potentials of
iPSC lines despite similar expressions of pluripotency factors
(Liu et al., 2010; Stadtfeld et al., 2010a). Our study provides an
epigenetic approach for evaluating the quality and develop-
mental potential of iPSC lines.
We discovered that H2A.X deposition pattern can distinguish
the developmental potentials of iPSC clones. Interestingly,
H2A.X dysfunction in 4N iPSCs results from an unexpected
deposition defect; the inaccurate H2A.X deposition in 4N
iPSCs clones are sufficient to prevent H2A.X from exerting its
functions at extraembryonic lineage genes without changing
the overall H2A.X protein levels. As such, H2A.X deposition
defects in 4N iPSCs are associated with upregulation of
extraembryonic genes and predispose these cells to extra-
embryonic lineage differentiation, both of which are reminiscent
of the H2A.X KO ESCs. In this regard, we revealed an ‘‘epige-
netic mutation’’ of H2A.X deposition in the 4N iPSCs
(Figure 7).tem Cell 15, 281–294, September 4, 2014 ª2014 Elsevier Inc. 289
(legend on next page)
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H2A.X Serves as an Epigenetic Mark for iPSCsPrevious mRNA expression microarray studies have impli-
cated aberrant silencing of the Dlk1-Dio3/Chr12qF1 locus in
4N iPSC clones. Our transcriptome profiling with the RNA-
seq also detected downregulation of the transcripts from this
locus (Liu et al., 2010; Stadtfeld et al., 2010a). Our preliminary
results indicated that aberrant accumulation of H2A.X at this
locus in 4N iPSCs may be a major cause for the aberrant
silencing (T.W. and A.X., unpublished data). Further investigation
is needed to elucidate the role of H2A.X at this locus.
Our work revealed that H2A.X deposition is cell-type specific
and redistribution of H2A.X deposition is closely connected
with cell fate transition. In ESCs but not differentiated cells
(MEFs) H2A.X is specifically deposited to extraembryonic
gene loci. In addition, H2A.X deposition at extraembryonic
genes is greatly reduced in TSCs, in agreement with their
elevated expression levels, which indicates that H2A.X deposi-
tion pattern may be intimately connected with developmental
potency of various stem cell lines. On the other hand, ESC-spe-
cific H2A.X deposition patterns can be recapitulated in a small
portion of the iPSC clones (4N+ iPSCs), but not in the majority
of the iPSC clones (4N iPSCs). Considering all iPSC lines in
the current studies were derived from the same parental cells,
it appears that variations of H2A.X deposition in iPSC clones
mostly likely occur during reprogramming when H2A.X deposi-
tion needs to be switched to an ESC-specific pattern. Intrigu-
ingly, several previous studies reported the upregulation of
g-H2A.X phosphorylation, an important functional readout of
H2A.X during reprogramming (Gonza´lez et al., 2013; Mario´n
et al., 2009; Mu¨ller et al., 2012). It is still unclear what signals
trigger g-H2A.X phosphorylation and how it is related to
H2A.X deposition. Taken together, these results support the
notion that H2A.X deposition pattern is closely correlated with
cell fate transitions.
Our investigations also lead to the identification of previously
uncharacterized functions of H2A.X. H2A.X specifically re-
presses extraembryonic genes in pluripotent stem cells. At the
molecular level, H2A.X is deposited to the enhancers bound by
Cdx2 during extraembryonic lineage differentiation. H2A.X occu-
pancy negatively regulates Cdx2 binding at these sites, which
may account for the repression function of H2A.X. Although
the exact mechanisms remain to be identified, H2A.X seems to
facilitate the heterochromatin formation at the enhancer sites in
ESCs and iPSCs. Intriguingly, H2A.X is enriched at large chro-
matin domains (100 kb on average), which often contain
multiple Cdx2-bound enhancer sites, much larger than the
known enhancer chromatin signatures, such as H3K4Me1 and
H3K27Me3 (Bilodeau et al., 2009; Rada-Iglesias et al., 2011).Figure 6. In Vivo Assays Distinguish the Developmental Potentials of i
(A) The control H2A.XFloxed/Floxed ESCs (H2A.X [f/f]) and H2A.X/ ESCs (generate
5 days, then injected into four-cell embryos and examined at the blastocyst stage
layer (white arrows) at a much higher frequency than the engrafted H2A.X (f/f) ES
(B) The 4N+ iPSCs and 4N iPSCs were cultured in TS media for 5 days (labeled w
and examined at the blastocyst stage. The engrafted 4N iPSCs contributed to t
than the engrafted 4N+ iPSCs (p = 0.01, Chi-square test).
(C) Top: engrafted H2A.X (f/f) ESCs that contributed to ICM (white arrows) were ne
the trophectoderm were costained with Cdx2 (white arrowheads).
(D) Top: engrafted 4N+ iPSCs that contributed to ICM were negative for Cdx2 s
trophectoderm were costained with Cdx2 (white arrowheads). See also Figure S
Cell SThese results suggest that H2A.X-mediated pathways represent
an additional mode of regulation for the high-order chromatin
structures at enhancer sites in pluripotent stem cells.
In summary, our studies revealed unexpected roles of histone-
variant H2A.X in repressing TE lineage genes in pluripotent stem
cells and showed that H2A.X deposition serves as a functional
epigenetic mark for distinguishing the developmental potentials
of mouse iPSC clones. These findings provide mechanistic
insight of epigenetic regulation of cellular reprogramming and
also pave the way for improving the fidelity of iPSCs. Future in-
vestigations will also shed light on whether this mark, or a related
approach using a different mark, will be applicable for evaluation
of human iPSC lines.
EXPERIMENTAL PROCEDURES
Cell Culture and Extraembryonic Lineage Differentiation
Mouse ESCs and iPSCs were cultured with recombinant leukemia inhibitory
factor and feeder-MEFs as previously described (Stadtfeld et al., 2010b).
When eliminating the feeder MEFs was necessary for the following experi-
ments, cells were selectively seeded on gelatin-coated plates. In extraembry-
onic lineage differentiation assays, Oct4 was turned off by removing doxycy-
cline in ESC harboring an inducible OCT4 construct (Ivanova et al., 2006); or
knocked down by lenti-viral shRNA in iPSCs (see Supplemental Experimental
Procedures for details). Cdx2 expression was induced by removing doxycy-
cline in ESCs harboring an inducible Cdx2 construct (Nishiyama et al., 2009;
see Supplemental Experimental Procedures for details). For trophectoderm
stem cell media culture, ES and iPSCs were cultured in TS differentiation
medium as described previously (Koh et al., 2011; see Supplemental Experi-
mental Procedures for details).
Immunoblotting and Immunofluorescence
Immunoblotting and immunofluorescence followed standard protocols (see
Supplemental Experimental Procedures for details and a list of antibodies
used in this study).
ChIP-Seq and Analysis Pipeline
Native ChIP assays were performed following standard protocols (see Supple-
mental Experimental Procedures for details). Copurified DNA and input
genomic DNA molecules were subject to library construction, cluster genera-
tion, and next-generation sequencing (Illumina Genome Analyzer II and HiSeq
2000). The output sequencing tags were filtered and preanalyzed with Illumina
standard workflow. See Supplemental Experimental Procedures for a list of
primers.
Validation of H2A.X Peaks with ChIP-qPCR and a Reconstitution
Approach
See Supplemental Experimental Procedures for details.
Bioinformatics Analysis of the ChIP-Seq Data
RSEG (Song and Smith, 2011; mode 2 or 3) was used to compare H2A.X
ChIP-seq results. H2A.X KO ESCs or MEFs as well as IgG ChIP signals werePSC Clones
d from H2A.X [f/f] + Cre) were labeled with H2B-GFP, cultured in TS media for
. The engrafted H2A.X/ ESCs contributed to the developing trophectoderm
Cs (p = 0.036, Chi-square test).
ith a red fluorescent dye, pKH26, Sigma), then injected into four-cell embryos,
he developing trophectoderm layer (white arrows) at a much higher frequency
gative for Cdx2 staining. Bottom: engraftedH2A.X/ ESCs that contributed to
taining (white arrows). Bottom: engrafted 4N iPSCs that contributed to the
6.
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Figure 7. A Model Illustrating the Functions
of H2A.X in ESCs and iPSCs
(A) In wild-type ESCs and 4N+ iPSCs, H2A.X is
deposited to extraembryonic genes, most of which
are downstream targets of Cdx2. H2A.X negatively
regulates Cdx2 binding via controlling chromatin
structures at enhancers and therefore, represses
the expression of these genes.
(B) In H2A.X-deficient ESCs, extraembryonic
genes are aberrantly regulated due to the lack of
H2A.X-mediated repression.
(C) In 4N iPSCs, H2A.X is not redistributed to the
extraembryonic genes. Because of this epigenetic
mutation, extraembryonic genes are aberrantly
regulated. Thus, these cells are primed to extra-
embryonic lineage differentiation.
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H2A.X Serves as an Epigenetic Mark for iPSCsused as negative controls for peak calling (see Supplemental Experimental
Procedures). To determine ESC- or MEF-specific H2A.X deposition, ESCs
ChIP-seq tags and MEFs ChIP-seq tags were used as ‘‘Sample’’ and
‘‘Control,’’ respectively.
Comparison between iPSC lines and other ESC lines: the ChIP-seq tags
of two additional ESC lines or iPSC lines, and those of control ESC (ESC_1),
were used as ‘‘Sample’’ and ‘‘Control,’’ respectively (see Supplemental
Experimental Procedures for details). TSCs and ESCs comparison followed
the same method.
CNV Detection
Comparative genomic hybridization experiments were performed with the
NimbleGen Mouse Tiling Array. The genomic DNA samples were purified
according to manufacturer’s protocols (QIAGEN DNeasy kit, Cat: 69504).292 Cell Stem Cell 15, 281–294, September 4, 2014 ª2014 Elsevier Inc.All other steps follow NimbleGen protocols
(see Supplemental Experimental Procedures for
details).
RNA-Seq and Validation by qRT-PCR
Approach
RNA was extracted with standard RNA extraction
protocol (Invitrogen). RNA was prepared for
sequencing using standard Illumina ‘‘TruSeq’’
stranded mRNA-seq library preparation protocols.
Fifty base pair sequencing was performed on an
Illumina HiSeq 2000 instrument at Yale Stem Cell
Center Genomics Core.
To validate the RNA-seq results, cDNA libraries
were generated the same RNA samples, and then
subject to quantitative PCR amplification with
specific primers (see Supplemental Experimental
Procedures for details).
Embryo Collection, ESCs, iPSCs,
and Four-Cell Embryo Injection
Mouse embryos were collected from ICR mice
(Charles River) that were superovulated following
standard procedures. Plugged females were killed
at 1.5 days after human chorionic gonadotropin
injection for the collection of two-cell embryos.
These embryos were flushed from the oviducts
with KSOM+ AA (Specialty Media) and cultured
for additional 12–14 hr in vitro. Embryos at the
four-cell stage were subjected to ESC injection.
H2A.X KO or WT ESCs were labeled with H2B-
GFP, whereas iPSCs were labeled with pKH26
red fluorescent cell linker kits (Sigma, pKH26GL)
as described by the manufacturer. A flat tip micro-injection pipette was used for ESC injection. ESCs were picked up in the end
of the injection pipette and 20–25 ESCs or iPSCs were injected into each
embryo. The injected embryos were cultured in KSOM+AA in vitro at 37C
under 5% CO2 in air until the blastocyst stage was reached. Embryos were
observed at the blastocyst stage and the number of embryos for ESCs or
iPSCs contribution was noted. Maintenance of the mouse colony was
overseen by the IUCAC (Institutional Animal Care and Use Committee) at
Yale and Cornell Universities.ACCESSION NUMBERS
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